SIBN
SI-BONE, Inc. (NASDAQ)
Healthcare — Medical Devices
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Price History
Fundamentals
| Market Cap | $749.95M |
| P/E Ratio (TTM) | - |
| Forward P/E | -47.92 |
| EPS (TTM) | $-0.39 |
| Dividend Yield | - |
| Profit Margin | -8.10% |
| Revenue Growth | 11.20% |
| ROE | -9.64% |
| Debt/Equity | 24.00 |
| Recommendation | None |
| Analyst Target | $24.13 |
| Analysts | 8 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 68.3 |
| Beta | 0.70 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $21.89 |
| 52-Week Low | $11.48 |
| 50-Day Avg | $14.50 |
| 200-Day Avg | $15.72 |
| Avg Volume | 664.4K |
| Volume | 278.2K |
Performance Analysis
BULLISHSIBN shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 02, 2026 13:31 UTC
Back to Screener Export Report